Compugen (Israel) Today
| CGEN Stock | ILA 533.00 2.50 0.47% |
PerformanceWeakest
| Odds Of DistressLow
|
Compugen is trading at 533.00 as of the 6th of February 2026, a 0.47% down since the beginning of the trading day. The stock's open price was 535.5. Compugen has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 8th of November 2025 and ending today, the 6th of February 2026. Click here to learn more.
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. The company has 86.62 M outstanding shares. More on Compugen
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Compugen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Compugen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Compugen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Anat CohenDayag |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Compugen (CGEN) is traded on Tel Aviv Stock Exchange in Israel and employs 73 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 251.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Compugen's market, we take the total number of its shares issued and multiply it by Compugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Compugen operates under Healthcare sector and is part of Biotechnology industry. The entity has 86.62 M outstanding shares.
Compugen has accumulated about 110.41 M in cash with (22.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32.
Check Compugen Probability Of Bankruptcy
Ownership AllocationCompugen holds a total of 86.62 Million outstanding shares. Compugen shows 5.5 percent of its outstanding shares held by insiders and 27.56 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Compugen Ownership Details
Compugen Risk Profiles
Although Compugen's alpha and beta are two of the key measurements used to evaluate Compugen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.56 | |||
| Standard Deviation | 3.43 | |||
| Variance | 11.79 | |||
| Risk Adjusted Performance | (0.01) |
Compugen Stock Against Markets
Compugen Stock Analysis Notes
About 28.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.13. Some equities with similar Price to Book (P/B) outperform the market in the long run. Compugen recorded a loss per share of 0.4. The entity had not issued any dividends in recent years. Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 68 people. For more info on Compugen please contact Anat CohenDayag at (972) 3 765 8555 or go to www.cgen.com.Compugen Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Compugen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Compugen or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Compugen had very high historical volatility over the last 90 days | |
| The company reported the revenue of 6 M. Net Loss for the year was (34.2 M) with profit before overhead, payroll, taxes, and interest of 5.32 M. | |
| Compugen has accumulated about 110.41 M in cash with (22.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32. |
Compugen Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 251.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Compugen's market, we take the total number of its shares issued and multiply it by Compugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 6th of February, Compugen shows the Standard Deviation of 3.43, risk adjusted performance of (0.01), and Mean Deviation of 2.56. Compugen technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Compugen Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Compugen Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Compugen price patterns.
Compugen Outstanding Bonds
Compugen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Compugen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Compugen bonds can be classified according to their maturity, which is the date when Compugen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Compugen Predictive Daily Indicators
Compugen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Compugen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 10676.18 | |||
| Daily Balance Of Power | (0.11) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 543.9 | |||
| Day Typical Price | 540.27 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (12.15) | |||
| Period Momentum Indicator | (2.50) |
Compugen Forecast Models
Compugen's time-series forecasting models are one of many Compugen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Compugen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Compugen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Compugen Corporate Directors
| Michal Preminger | Director | Profile | |
| Arie Ovadia | Independent External Director | Profile | |
| Eran Perry | Director | Profile | |
| Sanford Zweifach | Director | Profile |
Additional Information and Resources on Investing in Compugen Stock
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Compugen Stock refer to our How to Trade Compugen Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.